Skip to content

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting

Intervention to Enhance PrEP Uptake and Adherence in a Community-Based Setting

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02037594
Acronym
SPARK
Enrollment
438
Registered
2014-01-16
Start date
2014-01-30
Completion date
2018-06-01
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Immunodeficiency Virus (HIV)

Keywords

HIV, Pre-exposure prophylaxis, PrEP, MSM, Demonstration Project

Brief summary

This study identifies social and behavioral factors likely to influence PrEP acceptability and adherence among men who have sex with men (MSM), and collaborates with a community health center to evaluate a two-stage intervention to improve PrEP decision-making, as well as persistence and adherence for those who chose to take PrEP.

Detailed description

Pre-exposure prophylaxis (PrEP) refers to daily or intermittent oral administration of antiretroviral drugs designed to protect high-risk HIV-negative individuals from infection. In order for PrEP to become an effective prevention tool, three critical factors must be addressed: a) acceptability, i.e., individuals who would benefit from PrEP must know about it and be willing to take it; b) adherence, i.e., individuals who choose to PrEP as a prevention strategy must take the pills as prescribed; and c) implementation, i.e., processes and protocols must be developed to allow for the integration of PrEP delivery and programs into real world settings in a way that is feasible, scalable, and realistic. This project has three specific aims: 1) Identifying social and behavioral factors that are likely to influence PrEP implementation, acceptance, and use/adherence by men who have sex with men (MSM) in NYC, including factors at individual-, community-, and organizational-levels; 2) Examining social and behavioral factors associated with disparities in access to prevention and care services among MSM in NYC that might directly impact PrEP implementation programs and policies; and 3) Evaluating an intervention in which PrEP is introduced, provided, and supported as part of a prevention package delivered in an community health center. The project has the potential to exert a sustained and powerful influence not only on the effectiveness of PrEP interventions for MSM, but also on dissemination and scalability of a targeted intervention within community-based settings and in a manner that reduces disparities in access and maximizes cultural competence and acceptability.

Interventions

BEHAVIORALSexual Health Counseling

This brief intervention presents PrEP within the context of a patient's comprehensive sexual health plan and is designed to enhance decision-making around PrEP use and decrease sexual risk taking.

BEHAVIORALEnhanced Adherence Intervention

This brief intervention is provides standard of care PrEP adherence information plus specific counseling, troubleshooting, and support.

BEHAVIORALPrEP Information (Active Control)

Standard of Care Information about PrEP

BEHAVIORALStandard of Care Adherence Support (Active Control)

Standard of care information and instruction about PrEP adherence.

Sponsors

National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CollaboratorNIH
Gilead Sciences
CollaboratorINDUSTRY
Hunter College of City University of New York
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Registered patient receiving medical or health services at Callen-Lorde Community Health Center * Male sex (at birth) and reported sex with men or transwomen * At least 18 years of age * HIV-negative * At risk for HIV acquisition

Exclusion criteria

* Past history of PrEP use or currently taking PrEP

Design outcomes

Primary

MeasureTime frameDescription
PrEP UptakeBL through 3-monthsWhether or not the patient decides to take PrEP
PrEP PersistenceBL through 12-monthsWhether or not patients who decide to take PrEP persist with the medication for the duration of the study.
PrEP AdherenceBL through 12 monthsBiological measure of medication adherence using dried blood spots, and self-report measure of adherence using VAS.
Sexual Risk BehaviorBL through 12-monthsMeasured through STI testing and self-report.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026